The SCRS Digital Innovation Initiative decentralized trials workstream recently released a Best Practices and Recommendations for Site Participation on Decentralized Trials guide. Deena Bernstein, Vice President Customer Success at Datacubed Health , and Karen McIntyre, Senior Director, Patient Innovation Centre at Parexel, share how this resource was developed and how sites can utilize it effectively. 

We'll also discuss what should sites consider before initiating a trial with decentralized elements, and advice for sites that may be hesitant to engage these types of technologies.

In this episode, we are proud to highlight our 2022 Eagle Award sponsor recipient,  Merck. Jennifer Sheller, AVP, Clinical Trial Operations Leader with Merck discusses some of the site-focused programs her organization put in motion to earn the award and their plans to progress those initiatives. Jennifer also discusses Merck's response to the SCRS Open Letter to Industry Partners on sites' workforce and inflationary challenges, and what they took away from the SCRS Global Site Solutions Summit.

SCRS is hosting the second annual Diversity Site Solutions Summit in a few short weeks! Jackie Kent, VP of Strategy and Special Projects and Diversity with SCRS, and Kim Ribeiro, Head of Diversity & Patient Inclusion at AbbVie and co-chair of the SCRS Diversity Awareness Program discuss why an event like this is important for the industry, what makes this year's Summit different, and some of the exciting sessions to look forward to.  

SCRS Oncology Program participants Peter Fredette, Director, Clinical Partnerships Liaison with EQRx and Dan Otap, Principal, Alliance and Partnerships Lead at Genentech share information about helpful oncology resources for sites as well as some exciting new topics they are looking forward to discussing at this year's Global Oncology Site Solutions Summit.

If your site participates in oncology research, be sure to make your voice heard in the Oncology Site Landscape Survey today!

Unfunded, yet essential, study activities are a longstanding problem for the sustainability of studies and clinical research sites. These types of invoiceables, often called hidden costs, are typically not accounted for in the study budgeting process which can be detrimental to long-term site sustainability.  In this episode, David Vulcano, Honorary President, SCRS and Chris Hoyle, Executive Director, Elite Research Network, share information about the SCRS Site Invoiceables Toolkit created to help sites understand common billable items that a site should consider when assessing costs associated with a clinical trial. 

Dr. Queen Adaugo Ohandjo, Patient Advocate and Consultant with Proof Clinical Research, discusses how operational efficiencies at the clinical research site level can enable patient engagement and better patient outcomes. Learn how clinical trials can be designed to be more inclusive for diverse patients and how industry partners can support sites in these efforts to ensure successful trial outcomes.

Read more on this topic from Dr. Adaugo Ohandjo in the SCRS InFocus Newsletter.

Ellen Price, Senior Director of Patient Experience for Velocity Clinical Research, discusses insights from a patient experience survey they conducted with thousands of clinical trial participants. Ellen shares how they gathered the data, some surprising responses, and how other sites can garner participant feedback.

Read the white paper for more survey insights at https://velocityclinical.com/news

Most of us are aware of the telltale signs of heart disease in men. But what about women? Diana Reedie, Director, Clinic Management & Operations at LMC Healthcare and Vivienne van de Walle, Owner of PT&R, share their unique patient and physician perspectives on what women should know about cardiovascular disease. Listen as they highlight some of their personal experiences and advice as well as what the healthcare industry is still learning about women's heart health.

In honor of American Heart Month, we spoke with Dr. Michael Koren, Medical Director and CEO of ENCORE Research Group, as he shares his top tips for heart health – especially for busy professionals working in the clinical research industry. Dr. Koren also explores how cardiovascular research and treatment have progressed over the past several years as well as some exciting new learnings for this vital therapeutic area.

Nancy Trapp, Sr. Director, Field Management, North America Clinical Operations at Novo Nordisk, joins us to discuss why collaborating with clinical research sites is vital to her organization's success. Hear what Novo Nordisk is working on and how it will impact sites.